Large-scale testing (Phase 3)Study completedNCT06309992
What this trial is testing
Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)
Who this might be right for
ObesityNon-Alcoholic SteatoHepatitis (NASH)
Boehringer Ingelheim 218